Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Cell Biology International|July 5, 2018
Suppressed expression of Cbl-b by NF-κB mediates icotinib resistance in EGFR-mutant non-small-cell lung cancerTieqiong Zhang, Chunlei Zheng, Kezuo Hou, et al.
Peerj|May 24, 2019
Elevated limb-bud and heart development (LBH) expression indicates poor prognosis and promotes gastric cancer cell proliferation and invasion via upregulating Integrin/FAK/Akt pathwayRuoxi Yu, Zhi Li, Chuang Zhang, et al.
Annals of Translational Medicine|April 12, 2021
Distinct prognostic values of programmed death-ligand 1 and programmed cell death protein 1 in lung adenocarcinoma and squamous cell carcinoma patientsShuo Wang, Xiujuan Qu, Zhi Li, et al.
Functional & Integrative Genomics|July 2, 2008
Components of the gene network associated with genotype-dependent response of wheat to the Fusarium mycotoxin deoxynivalenolStephanie Walter, Josephine M Brennan, Chanemougasoundharam Arunachalam, et al.
Clinical Rheumatology|November 20, 2023
Response to belimumab among patients with refractory lupus nephritis: a real-world observational retrospective multicenter studyShuoyang Zhang, Qian Qiu, Shan Zeng, et al.
Oncogene|July 10, 2026
MTAP deficiency enhances collective metastasis in non-small cell lung cancer via WNT3A methylationYang Chen, Hongfei Yan, Ye Zhang, et al.
The International Journal of Biochemistry & Cell Biology|February 15, 2020
Loss of G-protein-signaling modulator 2 accelerates proliferation of lung adenocarcinoma via EGFR signaling pathwayMingming Deng, Bofang Liu, Zhe Zhang, et al.
Cell Biology International|December 24, 2017
miR-200a enhances TRAIL-induced apoptosis in gastric cancer cells by targeting A20Tianshu Guo, Ye Zhang, Xiujuan Qu, et al.
Biomarker Research|January 31, 2021
LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinomaJie Wu, Chunlei Zheng, Yizhe Wang, et al.
Pharmacological Research|June 21, 2020
Lymecycline reverses acquired EGFR-TKI resistance in non-small-cell lung cancer by targeting GRB2Yang Chen, Jie Wu, Hongfei Yan, et al.
Pageof 12